Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new human prostate carcinoma cell line, 22Rv1.

In vitro cellular & developmental biology. Animal - 1 Jan 2000

Sramkoski R M, Pretlow T G, Giaconia J M, Pretlow T P, Schwartz S, Sy M S, Marengo S R, Rhim J S, Zhang D, Jacobberger J W

Abstract excerpt

A cell line has been derived from a human prostatic carcinoma xenograft, CWR22R. This represents one of very few available cell lines representative of this disease. The cell line is derived from a xenograft that was serially propagated in mice after castration-induced regression and relapse of the parental, androgen-dependent CWR22 xenograft. Flow cytometric and cytogenetic analysis showed that this cell line...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Lineage
Share to Dihydrotestosterone

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Epidermal Growth Factor

Share to Karyotyping

Share to Mice, Nude

Share to Receptors, Androgen

Share to Transforming Growth Factor beta

Share to Transplantation, Heterologous

Source

Identifiers

PMID: 10462204
DOI: 10.1007/s11626-999-0115-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new human prostate carcinoma cell line, 22Rv1.PMID 10462204Read ↗

Androgen-regulated and highly tumorigenic human prostate cancer cell line established from a transplantable primary CWR22 tumor.Semantic proximity Read ↗

Molecular characterization of human prostate carcinoma cell linesSemantic proximity Read ↗

CELL LINES USED IN PROSTATE CANCER RESEARCH: A COMPENDIUM OF OLD AND NEW LINES—PART 2Semantic proximity Read ↗

CELL LINES USED IN PROSTATE CANCER RESEARCH: A COMPENDIUM OF OLD AND NEW LINES—PART 1Semantic proximity Read ↗

Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1Semantic proximity Read ↗

Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line.Semantic proximity Read ↗

How clinically relevant are prostate cancer cell lines? A comprehensive characterisation and multiomics comparisonSemantic proximity Read ↗

Expanding the Prostate Cancer Cell Line Repertoire with ACRJ-PC28, an AR-negative Neuroendocrine Cell Line Derived From an African-Caribbean PatientSemantic proximity Read ↗

A novel, spontaneously immortalized, human prostate cancer cell line, Bob, offers a unique model for pre-clinical prostate cancer studies.Semantic proximity Read ↗

PHENOTYPIC CHARACTERIZATION OF TWO NOVEL CELL LINE MODELS OF CASTRATION RESISTANT PROSTATE CANCERSemantic proximity Read ↗

How clinically relevant and inclusive are prostate cell lines?Semantic proximity Read ↗

Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.